Chongkundang Holdings Corp
KRX:001630
Chongkundang Holdings Corp
Gross Profit
Chongkundang Holdings Corp
Gross Profit Peer Comparison
Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors
Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Chongkundang Holdings Corp
KRX:001630
|
Gross Profit
₩383.9B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
14%
|
CAGR 10-Years
3%
|
|
Yuhan Corp
KRX:000100
|
Gross Profit
₩564.8B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
6%
|
CAGR 10-Years
7%
|
|
SK Biopharmaceuticals Co Ltd
KRX:326030
|
Gross Profit
₩320.8B
|
CAGR 3-Years
137%
|
CAGR 5-Years
211%
|
CAGR 10-Years
N/A
|
|
Hanmi Pharm Co Ltd
KRX:128940
|
Gross Profit
₩829.2B
|
CAGR 3-Years
13%
|
CAGR 5-Years
9%
|
CAGR 10-Years
7%
|
|
S
|
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
|
Gross Profit
₩98.2B
|
CAGR 3-Years
3%
|
CAGR 5-Years
2%
|
CAGR 10-Years
5%
|
C
|
Celltrion Pharm Inc
KOSDAQ:068760
|
Gross Profit
₩115.7B
|
CAGR 3-Years
13%
|
CAGR 5-Years
22%
|
CAGR 10-Years
13%
|
See Also
What is Chongkundang Holdings Corp's Gross Profit?
Gross Profit
383.9B
KRW
Based on the financial report for Dec 31, 2023, Chongkundang Holdings Corp's Gross Profit amounts to 383.9B KRW.
What is Chongkundang Holdings Corp's Gross Profit growth rate?
Gross Profit CAGR 10Y
3%
Over the last year, the Gross Profit growth was -4%. The average annual Gross Profit growth rates for Chongkundang Holdings Corp have been -2% over the past three years , 14% over the past five years , and 3% over the past ten years .